9 News & Press Releases found

Dynavax Technologies Corporation news

Dynavax to Present at the William Blair 42nd Annual Growth Stock Conference

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that

May. 25, 2022

Dynavax to Present at the H.C. Wainwright Global Investment Conference

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that

May. 16, 2022

Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dynavax Technologies Corporation (Nasdaq: DVAX) today reported that it has granted restricted stock units (RSUs) covering an aggregate of 16,000 shares of Dynavax common stock as inducements to 2 newly-hired employees in connection with commencement of employme

Mar. 3, 2022

Dynavax to Present at the Cowen 42nd Annual Health Care Conference

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that

Feb. 23, 2022

Dynavax to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 28, 2022

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company focused on developing and commercializing innovative vaccines, will report fourth quarter and full year 2021 financial results on Monday, February 28, 2022, after the

Feb. 16, 2022